$UNH
UNITEDHEALTH GROUP INC

2012 Q1 Form 10-Q Financial Statement

#000073176612000015 Filed on May 03, 2012

View on sec.gov

Income Statement

Concept 2012 Q1 2011 Q1
Revenue $27.28B $25.43B
YoY Change 7.27% 9.65%
Cost Of Revenue $634.0M $599.0M
YoY Change 5.84%
Gross Profit $26.65B $24.83B
YoY Change 7.31%
Gross Profit Margin 97.68% 97.64%
Selling, General & Admin $4.096B $3.617B
YoY Change 13.24% 10.41%
% of Gross Profit 15.37% 14.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $296.0M $270.0M
YoY Change 9.63% 8.87%
% of Gross Profit 1.11% 1.09%
Operating Expenses $4.096B $3.617B
YoY Change 13.24% -82.92%
Operating Profit $2.317B $2.221B
YoY Change 4.32% 10.17%
Interest Expense $148.0M $118.0M
YoY Change 25.42% -194.4%
% of Operating Profit 6.39% 5.31%
Other Income/Expense, Net
YoY Change
Pretax Income $2.169B $2.103B
YoY Change 3.14% 11.21%
Income Tax $781.0M $757.0M
% Of Pretax Income 36.01% 36.0%
Net Earnings $1.388B $1.346B
YoY Change 3.12% 13.01%
Net Earnings / Revenue 5.09% 5.29%
Basic Earnings Per Share $1.34 $1.24
Diluted Earnings Per Share $1.31 $1.22
COMMON SHARES
Basic Shares Outstanding 1.039B shares 1.086B shares
Diluted Shares Outstanding 1.060B shares 1.099B shares

Balance Sheet

Concept 2012 Q1 2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.82B
YoY Change
Cash & Equivalents $11.66B $9.790B
Short-Term Investments $19.16B
Other Short-Term Assets $698.0M $641.0M
YoY Change 8.89% 7.73%
Inventory
Prepaid Expenses
Receivables $2.688B
Other Receivables $1.978B
Total Short-Term Assets $22.69B $2.468B
YoY Change 819.37% 9.25%
LONG-TERM ASSETS
Property, Plant & Equipment $2.560B $2.189B
YoY Change 16.95% 5.75%
Goodwill $25.75B
YoY Change
Intangibles $3.103B
YoY Change
Long-Term Investments $19.16B $17.29B
YoY Change 10.79% 15.36%
Other Assets $2.091B $235.0M
YoY Change 789.79% -29.85%
Total Long-Term Assets $50.00B $62.87B
YoY Change -20.47% 9.75%
TOTAL ASSETS
Total Short-Term Assets $22.69B $2.468B
Total Long-Term Assets $50.00B $62.87B
Total Assets $72.69B $65.34B
YoY Change 11.26% 9.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.42B $15.93B
YoY Change 3.1% 1.65%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.771B $2.286B
YoY Change -22.53% -9.36%
Total Short-Term Liabilities $27.46B $18.21B
YoY Change 50.8% 0.13%
LONG-TERM LIABILITIES
Long-Term Debt $11.08B $9.359B
YoY Change 18.42% 16.97%
Other Long-Term Liabilities $8.302B $7.370B
YoY Change 12.65% 32.41%
Total Long-Term Liabilities $11.08B $16.73B
YoY Change -33.75% 23.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.46B $18.21B
Total Long-Term Liabilities $11.08B $16.73B
Total Liabilities $43.83B $38.76B
YoY Change 13.08% 10.06%
SHAREHOLDERS EQUITY
Retained Earnings $28.39B
YoY Change
Common Stock $10.00M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.86B $26.57B
YoY Change
Total Liabilities & Shareholders Equity $72.69B $65.34B
YoY Change 11.26% 9.73%

Cashflow Statement

Concept 2012 Q1 2011 Q1
OPERATING ACTIVITIES
Net Income $1.388B $1.346B
YoY Change 3.12% 13.01%
Depreciation, Depletion And Amortization $296.0M $270.0M
YoY Change 9.63% 8.87%
Cash From Operating Activities $3.586B $1.224B
YoY Change 192.97% 1.58%
INVESTING ACTIVITIES
Capital Expenditures $269.0M $213.0M
YoY Change 26.29% -261.36%
Acquisitions $1.935B $541.0M
YoY Change 257.67%
Other Investing Activities -$2.129B -$1.124B
YoY Change 89.41% 149.22%
Cash From Investing Activities -$2.398B -$1.337B
YoY Change 79.36% 129.33%
FINANCING ACTIVITIES
Cash Dividend Paid $168.0M $135.0M
YoY Change 24.44%
Common Stock Issuance & Retirement, Net $734.0M $524.0M
YoY Change 40.08%
Debt Paid & Issued, Net $0.00 $955.0M
YoY Change -100.0%
Cash From Financing Activities $1.044B $780.0M
YoY Change 33.85% -255.38%
NET CHANGE
Cash From Operating Activities $3.586B $1.224B
Cash From Investing Activities -$2.398B -$1.337B
Cash From Financing Activities $1.044B $780.0M
Net Change In Cash $2.232B $667.0M
YoY Change 234.63% 455.83%
FREE CASH FLOW
Cash From Operating Activities $3.586B $1.224B
Capital Expenditures $269.0M $213.0M
Free Cash Flow $3.317B $1.011B
YoY Change 228.09% -24.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6853000000 USD
CY2012Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6197000000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2294000000 USD
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2688000000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
458000000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
461000000 USD
CY2012Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
88000000 USD
CY2011Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
84000000 USD
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24000000 shares
CY2011Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
60000000 shares
CY2011Q4 us-gaap Assets
Assets
67889000000 USD
CY2012Q1 us-gaap Assets
Assets
72690000000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
22690000000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
20350000000 USD
CY2012Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
4281000000 USD
CY2012Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
4563000000 USD
CY2012Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
5945000000 USD
CY2012Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
6155000000 USD
CY2012Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
1684000000 USD
CY2012Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
1794000000 USD
CY2012Q1 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
17409000000 USD
CY2012Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2730000000 USD
CY2012Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2742000000 USD
CY2012Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18134000000 USD
CY2012Q1 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions
1600 positions
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9429000000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11661000000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9790000000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9123000000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
667000000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2232000000 USD
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1625
CY2011Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1039000000 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1033000000 shares
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1033000000 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1039000000 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
10000000 USD
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
10000000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1385000000 USD
CY2011Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1301000000 USD
CY2011Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
48000000 USD
CY2012Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
39000000 USD
CY2011Q1 us-gaap Cost Method Investments Realized Gains
CostMethodInvestmentsRealizedGains
53000000 USD
CY2012Q1 us-gaap Cost Method Investments Realized Gains
CostMethodInvestmentsRealizedGains
43000000 USD
CY2012Q1 us-gaap Cost Method Investments Realized Losses
CostMethodInvestmentsRealizedLosses
1000000 USD
CY2011Q1 us-gaap Cost Method Investments Realized Losses
CostMethodInvestmentsRealizedLosses
1000000 USD
CY2011Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
599000000 USD
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
634000000 USD
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
24965000000 USD
CY2011Q1 us-gaap Costs And Expenses
CostsAndExpenses
23211000000 USD
CY2011Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
11638000000 USD
CY2012Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
12854000000 USD
CY2012Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
13105000000 USD
CY2011Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
11860000000 USD
CY2012Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
126000000 USD
CY2011Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
165000000 USD
CY2012Q1 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
2845000000 USD
CY2011Q4 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
2574000000 USD
CY2012Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3816000000 USD
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1225000000 USD
CY2012Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
432000000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
472000000 USD
CY2011Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
270000000 USD
CY2012Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
296000000 USD
CY2012Q1 us-gaap Dividends Cash
DividendsCash
168000000 USD
CY2011Q1 us-gaap Dividends Cash
DividendsCash
135000000 USD
CY2011Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.24
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.34
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.31
CY2011Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2012Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
523000000 USD
CY2012Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition
1.1 Y
CY2012Q1 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
187000000 USD
CY2011Q1 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
57000000 USD
CY2012Q1 us-gaap Goodwill
Goodwill
25754000000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
23975000000 USD
CY2012Q1 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
195000000 USD
CY2012Q1 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
198000000 USD
CY2012Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
138000000 USD
CY2012Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
135000000 USD
CY2012Q1 us-gaap Held To Maturity Securities Debt Maturities After Ten Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue
46000000 USD
CY2012Q1 us-gaap Held To Maturity Securities Debt Maturities After Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount
43000000 USD
CY2012Q1 us-gaap Held To Maturity Securities Debt Maturities Fair Value
HeldToMaturitySecuritiesDebtMaturitiesFairValue
449000000 USD
CY2012Q1 us-gaap Held To Maturity Securities Debt Maturities Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmount
446000000 USD
CY2012Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
70000000 USD
CY2012Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
70000000 USD
CY2011Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2103000000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2169000000 USD
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
781000000 USD
CY2011Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
757000000 USD
CY2011Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
48000000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-202000000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
316000000 USD
CY2011Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
385000000 USD
CY2011Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-183000000 USD
CY2012Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-247000000 USD
CY2011Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-151000000 USD
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2465000000 USD
CY2011Q1 us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
143000000 USD
CY2012Q1 us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
246000000 USD
CY2011Q1 us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
1050000000 USD
CY2012Q1 us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
1137000000 USD
CY2012Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
221000000 USD
CY2011Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
304000000 USD
CY2011Q1 us-gaap Increase Decrease In Other Policyholder Funds
IncreaseDecreaseInOtherPolicyholderFunds
-8000000 USD
CY2012Q1 us-gaap Increase Decrease In Other Policyholder Funds
IncreaseDecreaseInOtherPolicyholderFunds
-248000000 USD
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2795000000 USD
CY2012Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3103000000 USD
CY2012Q1 us-gaap Interest Expense
InterestExpense
148000000 USD
CY2011Q1 us-gaap Interest Expense
InterestExpense
118000000 USD
CY2012Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
172000000 USD
CY2011Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
182000000 USD
CY2012Q1 us-gaap Liabilities
Liabilities
43834000000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
39597000000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
72690000000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67889000000 USD
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
27462000000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23922000000 USD
CY2012Q1 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
10221000000 USD
CY2011Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
9799000000 USD
CY2011Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
2445000000 USD
CY2012Q1 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
2444000000 USD
CY2012Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears
-530000000 USD
CY2011Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears
-440000000 USD
CY2011Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
982000000 USD
CY2012Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1771000000 USD
CY2012Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
14282000000 USD
CY2011Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
13149000000 USD
CY2012Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11083000000 USD
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10656000000 USD
CY2012Q1 us-gaap Long Term Investments
LongTermInvestments
16492000000 USD
CY2011Q4 us-gaap Long Term Investments
LongTermInvestments
16166000000 USD
CY2011Q4 us-gaap Marketable Securities
MarketableSecurities
18750000000 USD
CY2012Q1 us-gaap Marketable Securities
MarketableSecurities
19160000000 USD
CY2012Q1 us-gaap Marketable Securities Realized Gain Loss Other Than Temporary Impairments Amount
MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount
3000000 USD
CY2011Q1 us-gaap Marketable Securities Realized Gain Loss Other Than Temporary Impairments Amount
MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount
4000000 USD
CY2012Q1 us-gaap Mortgage Backed Securities Available For Sale Fair Value Disclosure
MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure
2880000000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1044000000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
780000000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2398000000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1337000000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3586000000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1224000000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
1388000000 USD
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
1346000000 USD
CY2012Q1 us-gaap Notional Amount Of Interest Rate Fair Value Hedge Derivatives
NotionalAmountOfInterestRateFairValueHedgeDerivatives
500000000 USD
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2221000000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2317000000 USD
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2091000000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2088000000 USD
CY2012Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
3000000 USD
CY2011Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
9000000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
-3000000 USD
CY2011Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
-45000000 USD
CY2012Q1 us-gaap Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax
OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax
-39000000 USD
CY2011Q1 us-gaap Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax
OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax
-48000000 USD
CY2011Q1 us-gaap Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
-31000000 USD
CY2012Q1 us-gaap Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
-25000000 USD
CY2011Q1 us-gaap Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Tax
OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax
-17000000 USD
CY2012Q1 us-gaap Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Tax
OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax
-14000000 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
30000000 USD
CY2011Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-37000000 USD
CY2011Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-23000000 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
19000000 USD
CY2011Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-14000000 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
11000000 USD
CY2011Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
23000000 USD
CY2012Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
88000000 USD
CY2011Q4 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
5063000000 USD
CY2012Q1 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
5457000000 USD
CY2011Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2255000000 USD
CY2012Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1978000000 USD
CY2012Q1 us-gaap Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest
OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterest
0 USD
CY2011Q1 us-gaap Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest
OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterest
0 USD
CY2011Q1 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
4000000 USD
CY2012Q1 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
3000000 USD
CY2012Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
991000000 USD
CY2011Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
620000000 USD
CY2011Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
135000000 USD
CY2012Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
168000000 USD
CY2012Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1935000000 USD
CY2011Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
541000000 USD
CY2012Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2326000000 USD
CY2011Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2716000000 USD
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
269000000 USD
CY2011Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
213000000 USD
CY2012Q1 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
19939000000 USD
CY2011Q1 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
18725000000 USD
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
23003000000 USD
CY2012Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
24631000000 USD
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
698000000 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
615000000 USD
CY2011Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
96000000 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
257000000 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
995000000 USD
CY2011Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
747000000 USD
CY2012Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1098000000 USD
CY2011Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1048000000 USD
CY2011Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
21000000 USD
CY2012Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-183000000 USD
CY2012Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
244000000 USD
CY2011Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
759000000 USD
CY2011Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
1085000000 USD
CY2012Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
1034000000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2515000000 USD
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2560000000 USD
CY2011Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
955000000 USD
CY2012Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
28388000000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
27821000000 USD
CY2012Q1 us-gaap Revenues
Revenues
27282000000 USD
CY2011Q1 us-gaap Revenues
Revenues
25432000000 USD
CY2012Q1 us-gaap Revenues From External Customers
RevenuesFromExternalCustomers
27110000000 USD
CY2011Q1 us-gaap Revenues From External Customers
RevenuesFromExternalCustomers
25250000000 USD
CY2011Q1 us-gaap Revenues From Transactions With Other Operating Segments Of Same Entity
RevenuesFromTransactionsWithOtherOperatingSegmentsOfSameEntity
0 USD
CY2012Q1 us-gaap Revenues From Transactions With Other Operating Segments Of Same Entity
RevenuesFromTransactionsWithOtherOperatingSegmentsOfSameEntity
0 USD
CY2011Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
649000000 USD
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
688000000 USD
CY2012Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
1791000000 USD
CY2011Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
1598000000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
28292000000 USD
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4096000000 USD
CY2011Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3617000000 USD
CY2011Q1 us-gaap Share Based Compensation
ShareBasedCompensation
123000000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
140000000 USD
CY2011Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.012
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.013
CY2011Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
4.9 Y
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.434
CY2011Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.443
CY2011Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.023
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
45
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm
4.1 years
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
36
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
44
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
52
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1266000000 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
43
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1254000000 USD
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
43
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
4.5 years
CY2012Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
974000000 USD
CY2012Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
4.5 years
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
2577000000 USD
CY2012Q1 us-gaap Short Term Investments
ShortTermInvestments
2665000000 USD
CY2012Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
129000000 USD
CY2011Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
61000000 USD
CY2012Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
209000000 USD
CY2011Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
139000000 USD
CY2012Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
991000000 USD
CY2011Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
620000000 USD
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
28856000000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
25825000000 USD
CY2011Q1 us-gaap Stockholders Equity
StockholdersEquity
26571000000 USD
CY2012Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These Condensed Consolidated Financial Statements include certain amounts based on the Company&#8217;s best estimates and judgments. The Company&#8217;s most significant estimates relate to medical costs payable and medical costs, premium rebates and risk-sharing provisions related to revenues, valuation and impairment analysis of goodwill and other intangible assets, other policy liabilities, other current receivables, valuation of investments, income taxes and contingent liabilities. These estimates require the application of complex assumptions and judgments, often because they involve matters that are inherently uncertain and will likely change in subsequent periods. The impact of any changes in estimates is included in earnings in the period in which the estimate is adjusted.</font></div></div>
CY2012Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
21000000 shares
CY2011Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13000000 shares
CY2011Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1099000000 shares
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1060000000 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1039000000 shares
CY2011Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1086000000 shares
CY2012Q1 unh Aarp Assets Under Management
AarpAssetsUnderManagement
2568000000 USD
CY2011Q4 unh Aarp Assets Under Management
AarpAssetsUnderManagement
2708000000 USD
CY2012Q1 unh Commercial Mortage Loans In Default
CommercialMortageLoansInDefault
7000000 USD
CY2011Q4 unh Marketable Securities Amortized Cost
MarketableSecuritiesAmortizedCost
17988000000 USD
CY2012Q1 unh Marketable Securities Amortized Cost
MarketableSecuritiesAmortizedCost
18411000000 USD
CY2011Q4 unh Marketable Securities Unrealized Gains
MarketableSecuritiesUnrealizedGains
794000000 USD
CY2012Q1 unh Marketable Securities Unrealized Gains
MarketableSecuritiesUnrealizedGains
768000000 USD
CY2011Q4 unh Marketable Securities Unrealized Losses
MarketableSecuritiesUnrealizedLosses
32000000 USD
CY2012Q1 unh Marketable Securities Unrealized Losses
MarketableSecuritiesUnrealizedLosses
19000000 USD
CY2012Q1 unh Number Of Reportable Segments
NumberOfReportableSegments
4
CY2012Q1 unh Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures
0.05
CY2011Q1 unh Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures
0.05
CY2012Q1 unh Share Based Compensation Arrangement By Share Based Payment Award Options And Sars Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSarsExercisableNumber
67000000 shares
CY2012Q1 unh Share Based Compensation Arrangement By Share Based Payment Award Options And Sars Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSarsExercisesInPeriod
11000000 shares
CY2012Q1 unh Share Based Compensation Arrangement By Share Based Payment Award Options And Sars Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSarsForfeituresInPeriod
1000000 shares
CY2012Q1 unh Share Based Compensation Arrangement By Share Based Payment Award Options And Sars Grants In Period Net Of Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSarsGrantsInPeriodNetOfForfeitures
94000 shares
CY2011Q4 unh Share Based Compensation Arrangement By Share Based Payment Award Options And Sars Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSarsOutstandingNumber
91000000 shares
CY2012Q1 unh Share Based Compensation Arrangement By Share Based Payment Award Options And Sars Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSarsOutstandingNumber
79000000 shares
CY2012Q1 unh Share Based Compensation Arrangement By Share Based Payment Award Options And Sars Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSarsVestedAndExpectedToVestOutstandingNumber
78000000 shares
CY2012Q1 unh Total Number Of Security Positions
TotalNumberOfSecurityPositions
16100 positions
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000731766
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1037448473 shares
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
UNITEDHEALTH GROUP INC

Files In Submission

Name View Source Status
0000731766-12-000015-index-headers.html Edgar Link pending
0000731766-12-000015-index.html Edgar Link pending
0000731766-12-000015.txt Edgar Link pending
0000731766-12-000015-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uhglogo1.jpg Edgar Link pending
unh-20120331.xml Edgar Link completed
unh-20120331.xsd Edgar Link pending
unh-20120331_cal.xml Edgar Link unprocessable
unh-20120331_def.xml Edgar Link unprocessable
unh-20120331_lab.xml Edgar Link unprocessable
unh-20120331_pre.xml Edgar Link unprocessable
unh201233110q.htm Edgar Link pending
unhex101331201210q.htm Edgar Link pending
unhex121331201210q.htm Edgar Link pending
unhex311331201210q.htm Edgar Link pending
unhex321331201210q.htm Edgar Link pending